Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies Elizabeth Masencup January 5, 2023
BWXT Promotes Chip Whitford to Senior Vice President and General Counsel Elizabeth Masencup January 4, 2023
BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor Elizabeth Masencup December 7, 2022
BWX Technologies to Announce Third Quarter 2022 Results on Monday, November 7 Elizabeth Masencup October 12, 2022
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA Elizabeth Masencup September 13, 2022
